K
Kezar Life Sciences D
D
KZR
4.45000
USD
0.37
(9.07%)
مغلق
حجم التداول
1,828
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
32,510,810
الأخبار المقالات
العنوان: Kezar Life Sciences Inc
القطاع: Healthcare
الصناعة: Biotechnology
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.